Skip to content

Identification of Sudden Deafness by cf-DNA 5 hmC Molecular Markers and Study on the Efficacy Prediction

Identification of Sudden Deafness by cf-DNA 5 hmC Molecular Markers and Study on the Efficacy Prediction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077365
Enrollment
Unknown
Registered
2023-11-06
Start date
2023-06-15
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sudden sensorineural hearing loss

Interventions

Low frequency falling type:Treat according to the guidelines for diagnosis and treatment of sudden deafness
high frequency falling type:Treat according to the guidelines for diagnosis and treatment of sudden deafness
Flat descent type:Treat according to the guidelines for diagnosis and treatment of sudden deafness
Total deafness:Treat according to the guidelines for diagnosis and treatment of sudden deafness
Validation group:Treat according to the guidelines for diagnosis and treatment of sudden deafness

Sponsors

Hainan hospital of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Select patients with sudden deafness diagnosed in our hospital according to the guidelines for diagnosis and treatment of sudden deafness

Exclusion criteria

Exclusion criteria: The basic information of patients is incomplete; No blood sample is taken; No audiological examination in our hospital (pure tone audiometry, acoustic immittance); Treatment not according to guidelines

Design outcomes

Primary

MeasureTime frame
Pure tone audiometry;5hmc;

Secondary

MeasureTime frame
age;gender;

Countries

China

Contacts

Public ContactLi Xinjian

Hainan hospital of PLA General Hospital

lixinjianhnfy@163.com+86 156 9253 8570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026